Literature DB >> 29186448

Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda.

Denali Boon1,2, Andrew D Redd1,3, Oliver Laeyendecker1,2,3, Ronald E Engle1, Hanh Nguyen1, Ponsiano Ocama4, Iga Boaz5, Anthony Ndyanabo5, Valerian Kiggundu5, Steven J Reynolds1,3, Ronald H Gray2,5, Maria J Wawer2,5, Robert H Purcell1, Gregory D Kirk2, Thomas C Quinn1, Lara Stabinski1.   

Abstract

A cross-sectional study was conducted of 500 human immunodeficiency virus (HIV)-infected adults frequency matched on age, sex, and community to 500 HIV-uninfected individuals in the Rakai District, Uganda to evaluate seroprevalence of anti-hepatitis E virus (HEV) IgG antibodies. HEV seroprevalence was 47%, and 1 HIV-infected individual was actively infected with a genotype 3 virus. Using modified Poisson regression, male sex (prevalence ratios [PR] = 1.247; 95% confidence interval [CI], 1.071-1.450) and chronic hepatitis B virus infection (PR = 1.377; 95% CI, 1.090-1.738) were associated with HEV seroprevalence. HIV infection status (PR = 0.973; 95% CI, 0.852-1.111) was not associated with HEV seroprevalence. These data suggest there is a large burden of prior exposure to HEV in rural Uganda. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  HEV seroprevalence; Rakai; Uganda; hepatitis E virus; viral hepatitis

Mesh:

Substances:

Year:  2018        PMID: 29186448      PMCID: PMC5853830          DOI: 10.1093/infdis/jix610

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR.

Authors:  Reimar Johne; Anita Plenge-Bönig; Michael Hess; Rainer G Ulrich; Jochen Reetz; Anika Schielke
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

Review 3.  The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.

Authors:  Kenrad E Nelson; Brittany Kmush; Alain B Labrique
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

4.  Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences.

Authors:  Claro Yu; Denali Boon; Shannon L McDonald; Timothy G Myers; Keiko Tomioka; Hanh Nguyen; Ronald E Engle; Sugantha Govindarajan; Suzanne U Emerson; Robert H Purcell
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

5.  Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.

Authors:  Timothy J Davern; Naga Chalasani; Robert J Fontana; Paul H Hayashi; Petr Protiva; David E Kleiner; Ronald E Engle; Hanh Nguyen; Suzanne U Emerson; Robert H Purcell; Hans L Tillmann; Jiezhun Gu; Jose Serrano; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2011-08-16       Impact factor: 22.682

6.  High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda.

Authors:  Lara Stabinski; Steven J Reynolds; Ponsiano Ocama; Oliver Laeyendecker; Anthony Ndyanabo; Valerian Kiggundu; Iga Boaz; Ron H Gray; Maria Wawer; Chloe Thio; David L Thomas; Thomas C Quinn; Gregory D Kirk
Journal:  Antivir Ther       Date:  2011

7.  A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus.

Authors:  Narayanan Jothikumar; Theresa L Cromeans; Betty H Robertson; X J Meng; Vincent R Hill
Journal:  J Virol Methods       Date:  2005-08-24       Impact factor: 2.014

8.  Pathobiology of hepatitis E: lessons learned from primate models.

Authors:  Robert H Purcell; Ronald E Engle; Sugantha Govindarajan; Richard Herbert; Marisa St Claire; William R Elkins; Anthony Cook; Charlene Shaver; Michelle Beauregard; Joanne Swerczek; Suzanne U Emerson
Journal:  Emerg Microbes Infect       Date:  2013-03-13       Impact factor: 7.163

9.  Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa.

Authors:  Jong-Hoon Kim; Kenrad E Nelson; Ursula Panzner; Yogita Kasture; Alain B Labrique; Thomas F Wierzba
Journal:  BMC Infect Dis       Date:  2017-03-03       Impact factor: 3.090

10.  Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio.

Authors:  Aluísio J D Barros; Vânia N Hirakata
Journal:  BMC Med Res Methodol       Date:  2003-10-20       Impact factor: 4.615

View more
  9 in total

1.  Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis.

Authors:  Lucy Platt; Clare E French; Catherine R McGowan; Keith Sabin; Erin Gower; Adam Trickey; Bethan McDonald; Jason Ong; Jack Stone; Philippa Easterbrook; Peter Vickerman
Journal:  J Viral Hepat       Date:  2019-12-22       Impact factor: 3.728

2.  Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.

Authors:  Reza Shahriarirad; Amirhossein Erfani; Mohammad Rastegarian; Ali Zeighami; Nasir Arefkhah; Fariba Ghorbani; Jamal Sarvari; Bahador Sarkari
Journal:  Virol J       Date:  2020-07-17       Impact factor: 4.099

3.  Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017.

Authors:  R Bassal; M Wax; R Shirazi; T Shohat; D Cohen; D David; S Abu-Mouch; Y Abu-Ghanem; E Mendelson; Z Ben-Ari; O Mor
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

4.  Hepatitis E Infection in HIV-Infected Patients.

Authors:  Antonio Rivero-Juarez; Pedro Lopez-Lopez; Mario Frias; Antonio Rivero
Journal:  Front Microbiol       Date:  2019-06-26       Impact factor: 5.640

Review 5.  Mode and tempo of human hepatitis virus evolution.

Authors:  Rachele Cagliani; Diego Forni; Manuela Sironi
Journal:  Comput Struct Biotechnol J       Date:  2019-10-25       Impact factor: 7.271

Review 6.  Human Immunodeficiency Virus Infected Patients are Not at Higher Risk for Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis.

Authors:  Pedro Lopez-Lopez; Mario Frias; Angela Camacho; Antonio Rivero; Antonio Rivero-Juarez
Journal:  Microorganisms       Date:  2019-11-26

7.  The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.

Authors:  Ronnie Kasirye; Heather A Hume; Evan M Bloch; Irene Lubega; Dorothy Kyeyune; Ruchee Shrestha; Henry Ddungu; Hellen Wambongo Musana; Aggrey Dhabangi; Joseph Ouma; Priscilla Eroju; Telsa de Lange; Michael Tartakovsky; Jodie L White; Ceasar Kakura; Mary Glenn Fowler; Philippa Musoke; Monica Nolan; M Kate Grabowski; Lawrence H Moulton; Susan L Stramer; Denise Whitby; Peter A Zimmerman; Deo Wabwire; Isaac Kajja; Jeffrey McCullough; Raymond Goodrich; Thomas C Quinn; Robert Cortes; Paul M Ness; Aaron A R Tobian
Journal:  Trials       Date:  2022-04-04       Impact factor: 2.279

8.  Prevalence and viral loads of polyomaviruses BKPyV, JCPyV, MCPyV, TSPyV and NJPyV and hepatitis viruses HBV, HCV and HEV in HIV-infected patients in China.

Authors:  Xianfeng Zhou; Kenji Nakashima; Masahiko Ito; Xiaoling Zhang; Satoshi Sakai; Changhua Feng; Huabao Sun; Haiying Chen; Tian-Cheng Li; Tetsuro Suzuki
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

9.  Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors.

Authors:  Aybüke Koyuncu; Daniel Mapemba; Iza Ciglenecki; Emily S Gurley; Andrew S Azman
Journal:  Open Forum Infect Dis       Date:  2021-04-13       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.